Year |
Citation |
Score |
2019 |
Zhao Y, Alakhova DY, Zhao X, Band V, Batrakova EV, Kabanov AV. Eradication of Cancer stem cells in triple negative breast Cancer using Doxorubicin/Pluronic polymeric micelles. Nanomedicine : Nanotechnology, Biology, and Medicine. 102124. PMID 31756533 DOI: 10.1016/J.Nano.2019.102124 |
0.516 |
|
2019 |
Hu H, Petrosyan A, Osna NA, Liu T, Olou AA, Alakhova DY, Singh PK, Kabanov AV, Faber EA, Bronich TK. Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31121280 DOI: 10.1016/J.Jconrel.2019.05.026 |
0.488 |
|
2016 |
He Z, Wan X, Schulz A, Bludau H, Dobrovolskaia MA, Stern ST, Montgomery SA, Yuan H, Li Z, Alakhova D, Sokolsky M, Darr DB, Perou CM, Jordan R, Luxenhofer R, et al. A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials. 101: 296-309. PMID 27315213 DOI: 10.1016/J.Biomaterials.2016.06.002 |
0.515 |
|
2016 |
Mahajan V, Gaymalov Z, Alakhova D, Gupta R, Zucker IH, Kabanov AV. Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers. Data in Brief. 7: 1269-82. PMID 27222845 DOI: 10.1016/J.Dib.2016.03.087 |
0.706 |
|
2016 |
Mahajan V, Gaymalov Z, Alakhova D, Gupta R, Zucker IH, Kabanov AV. Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers Data in Brief. 7: 1269-1282. DOI: 10.1016/j.dib.2016.03.087 |
0.706 |
|
2015 |
Mahajan V, Gaymalov Z, Alakhova D, Gupta R, Zucker IH, Kabanov AV. Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers. Biomaterials. 75: 58-70. PMID 26480472 DOI: 10.1016/J.Biomaterials.2015.10.002 |
0.699 |
|
2015 |
Alakhova DY, Kabanov AV. Nanomedicine and nanotechnology are rapidly developing fields across the nation and worldwide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 208: 1. PMID 25965907 DOI: 10.1016/J.Jconrel.2015.04.044 |
0.424 |
|
2015 |
He Z, Schulz A, Wan X, Seitz J, Bludau H, Alakhova DY, Darr DB, Perou CM, Jordan R, Ojima I, Kabanov AV, Luxenhofer R. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 208: 67-75. PMID 25725361 DOI: 10.1016/J.Jconrel.2015.02.024 |
0.538 |
|
2014 |
Alakhova DY, Kabanov AV. Pluronics and MDR reversal: an update. Molecular Pharmaceutics. 11: 2566-78. PMID 24950236 DOI: 10.1021/Mp500298Q |
0.571 |
|
2014 |
Alakhova DY, Kabanov AY. Drug Delivery in Oncology. From Basic Research to Cancer Therapy. 3 Volumes. Edited by Felix Kratz, Peter Senter and Henning Steinhagen. Angewandte Chemie International Edition. 53: 3547-3548. DOI: 10.1002/Anie.201309567 |
0.321 |
|
2014 |
Alakhova DY, Kabanov AY. Drug Delivery in Oncology. From Basic Research to Cancer Therapy. 3 Bände. Herausgegeben von Felix Kratz, Peter Senter und Henning Steinhagen. Angewandte Chemie. 126: 3617-3618. DOI: 10.1002/Ange.201309567 |
0.317 |
|
2013 |
Zhao Y, Alakhova DY, Kabanov AV. Can nanomedicines kill cancer stem cells? Advanced Drug Delivery Reviews. 65: 1763-83. PMID 24120657 DOI: 10.1016/J.Addr.2013.09.016 |
0.537 |
|
2013 |
Alakhova DY, Zhao Y, Li S, Kabanov AV. Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia. Plos One. 8: e72238. PMID 23977261 DOI: 10.1371/Journal.Pone.0072238 |
0.522 |
|
2013 |
Zhao Y, Alakhova DY, Kim JO, Bronich TK, Kabanov AV. A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 168: 61-9. PMID 23474033 DOI: 10.1016/J.Jconrel.2013.02.026 |
0.523 |
|
2011 |
Luxenhofer R, Sahay G, Schulz A, Alakhova D, Bronich TK, Jordan R, Kabanov AV. Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 153: 73-82. PMID 21513750 DOI: 10.1016/J.Jconrel.2011.04.010 |
0.651 |
|
2010 |
Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. Journal of Controlled Release : Official Journal of the Controlled Release Society. 145: 182-95. PMID 20226220 DOI: 10.1016/J.Jconrel.2010.01.036 |
0.657 |
|
2010 |
Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV. Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 89-100. PMID 19815037 DOI: 10.1016/J.Jconrel.2009.09.026 |
0.541 |
|
2009 |
Zhang X, Alakhova DY, Batrakova EV, Li S, Yang Z, Li Y, Kabanov AV. Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 4: 35-46. PMID 18677571 DOI: 10.1007/S11481-008-9119-1 |
0.451 |
|
2006 |
Batrakova EV, Kelly DL, Li S, Li Y, Yang Z, Xiao L, Alakhova DY, Sherman S, Alakhov VY, Kabanov AV. Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Molecular Pharmaceutics. 3: 113-23. PMID 16579640 DOI: 10.1021/Mp050050G |
0.582 |
|
Show low-probability matches. |